{"id":"placebo-lng","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo-LNG refers to an inert control formulation used in a Phase 3 trial, likely comparing against a levonorgestrel (LNG)-based contraceptive or hormonal therapy. The placebo arm provides no pharmacological effect and serves as the comparator to establish efficacy of the active treatment.","oneSentence":"This is a placebo control arm in a clinical trial and contains no active pharmaceutical ingredient.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:51:31.023Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 trial (specific indication unknown)"}]},"trialDetails":[{"nctId":"NCT07449299","phase":"PHASE3","title":"Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel","status":"NOT_YET_RECRUITING","sponsor":"University of Utah","startDate":"2027-03","conditions":"Emergency Contraception, Contraception, COX-2 Inhibitor","enrollment":1458},{"nctId":"NCT05829460","phase":"PHASE2","title":"Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia","status":"WITHDRAWN","sponsor":"Washington University School of Medicine","startDate":"2025-03-12","conditions":"Endometrial Hyperplasia","enrollment":""},{"nctId":"NCT03455075","phase":"PHASE2","title":"Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men","status":"COMPLETED","sponsor":"Premier Research","startDate":"2018-04-16","conditions":"Healthy, Men, Male Contraception","enrollment":92},{"nctId":"NCT06162611","phase":"PHASE4","title":"Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo","status":"RECRUITING","sponsor":"Lori Gawron","startDate":"2023-11-06","conditions":"Emergency Contraception","enrollment":790},{"nctId":"NCT04948489","phase":"PHASE2","title":"IUD and Norethindrone Acetate for Treatment of Endometriosis","status":"WITHDRAWN","sponsor":"Boston Children's Hospital","startDate":"2026-01-01","conditions":"Endometriosis","enrollment":""},{"nctId":"NCT06727734","phase":"PHASE3","title":"Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2024-12","conditions":"Contraception","enrollment":980},{"nctId":"NCT00131885","phase":"PHASE4","title":"Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel","status":"COMPLETED","sponsor":"University of Utah","startDate":"2005-08","conditions":"Contraception","enrollment":36},{"nctId":"NCT05770297","phase":"NA","title":"Effect of Propolis Administration for Dysmenorrhea in Endometriosis Patient With Levonorgestrel Implant Therapy","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2022-07-12","conditions":"Endometriosis, Dysmenorrhea","enrollment":24},{"nctId":"NCT04339348","phase":"PHASE3","title":"Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-04-30","conditions":"Contraception","enrollment":210},{"nctId":"NCT04355598","phase":"PHASE4","title":"Cervical Lidocaine-Prilocaine Cream vs Glyceryl Trinitrate Cream in Nulliparous Women With LNG-IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-04-30","conditions":"Contraception","enrollment":195},{"nctId":"NCT04312061","phase":"PHASE3","title":"Effect of Oral Tramadol Administration Prior to IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-30","conditions":"Contraception","enrollment":108},{"nctId":"NCT04311658","phase":"PHASE3","title":"Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-30","conditions":"Contraception","enrollment":88},{"nctId":"NCT04301349","phase":"PHASE3","title":"Dinoprostone vs Misoprostol Before LNG-IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-15","conditions":"IUD Insertion Pain","enrollment":200},{"nctId":"NCT03762382","phase":"PHASE2","title":"Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring","status":"UNKNOWN","sponsor":"CONRAD","startDate":"2018-12-12","conditions":"HIV, Contraception, Prevention","enrollment":50},{"nctId":"NCT03279120","phase":"PHASE1","title":"Safety, PK, and PD Study of IVRs Releasing TFV and LNG","status":"COMPLETED","sponsor":"CONRAD","startDate":"2017-09-28","conditions":"Anti-Infective Agents, Anti-Retroviral Agents, Contraceptive Usage","enrollment":66},{"nctId":"NCT02824224","phase":"PHASE4","title":"Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2016-09-06","conditions":"Menorrhagia, Metrorrhagia, Medicated Intrauterine Devices","enrollment":42},{"nctId":"NCT03210246","phase":"PHASE1","title":"Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-07-17","conditions":"Clinical Trial ,Phase I","enrollment":71},{"nctId":"NCT00789802","phase":"NA","title":"A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUC","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2008-11","conditions":"Contraception, Bleeding","enrollment":129},{"nctId":"NCT02957630","phase":"PHASE1, PHASE2","title":"\"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study\"","status":"COMPLETED","sponsor":"Estetra","startDate":"2016-09","conditions":"Contraception, Liver Metabolism, Hemostasis Parameter","enrollment":101},{"nctId":"NCT01963403","phase":"PHASE4","title":"Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive","status":"TERMINATED","sponsor":"University of California, Davis","startDate":"2013-12","conditions":"Abnormal Uterine Bleeding, Unspecified, Uterine Bleeding Heavy","enrollment":26},{"nctId":"NCT00781456","phase":"PHASE2","title":"A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2009-01","conditions":"Migraine","enrollment":109},{"nctId":"NCT01931657","phase":"PHASE2","title":"Pretreatment With Mifepristone Prior to Mirena Insertion","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2013-08","conditions":"Women in Need of Long Acting Reversibel Cntraception With the Intrauterine Levonorgestrel Releasing System, Mirena","enrollment":60},{"nctId":"NCT00778609","phase":"PHASE3","title":"Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-12","conditions":"Oral Contraceptive, Headache, Pelvic Pain","enrollment":449},{"nctId":"NCT02235662","phase":"PHASE1","title":"Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone","status":"COMPLETED","sponsor":"CONRAD","startDate":"2014-10","conditions":"HIV, Contraception","enrollment":86},{"nctId":"NCT01401114","phase":"","title":"Wellnara Post-marketing Surveillance in Japan","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-03","conditions":"Osteoporosis, Postmenopausal","enrollment":411},{"nctId":"NCT01421368","phase":"PHASE1","title":"Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-03","conditions":"HIV Prevention","enrollment":72},{"nctId":"NCT00764881","phase":"PHASE3","title":"Effects of SH T00658ID on Libido","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-01","conditions":"Contraception, Libido","enrollment":217},{"nctId":"NCT00480532","phase":"NA","title":"A Study of Continuous Oral Contraceptives and Doxycycline","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2007-05","conditions":"Contraceptives, Oral","enrollment":131},{"nctId":"NCT00924560","phase":"PHASE2","title":"A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2009-06","conditions":"Bone Mineral Density","enrollment":1361},{"nctId":"NCT00318799","phase":"PHASE2","title":"Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-04","conditions":"Pregnancy, Unplanned","enrollment":29},{"nctId":"NCT00394771","phase":"PHASE2","title":"A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2006-10","conditions":"Breakthrough Bleeding","enrollment":567},{"nctId":"NCT00161681","phase":"PHASE3","title":"Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-07","conditions":"Premenstrual Syndrome","enrollment":200},{"nctId":"NCT00185367","phase":"PHASE3","title":"Comparative Cycle Control Europe","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-03","conditions":"Contraception","enrollment":798},{"nctId":"NCT00185224","phase":"PHASE2","title":"Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-03","conditions":"Contraception","enrollment":58},{"nctId":"NCT00128934","phase":"PHASE3","title":"Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-08","conditions":"Menstruation Disturbances, Premenstrual Syndrome","enrollment":744}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo - LNG","genericName":"Placebo - LNG","companyName":"The University of Hong Kong","companyId":"the-university-of-hong-kong","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control arm in a clinical trial and contains no active pharmaceutical ingredient. Used for Control arm in Phase 3 trial (specific indication unknown).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}